Relationship Between Prostate-specific Antigen and Hematocrit: Does Hemodilution Lead to Lower PSA Concentrations in Men With a Higher Body Mass Index?

Urology

Volumn 75, Issue 3, 2010, Pages 648-652

  Ohwaki, Kazuhiro ^a   Endo, Fumiyasu ^b   Muraishi, Osamu ^b   Hiramatsu, Sonoe ^b   Yano, Eiji ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; GROUPS BY AGE; HEMATOCRIT; HEMODILUTION; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EXAMINATION; NORMAL HUMAN; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADULT; BODY MASS INDEX; HEMATOCRIT; HEMODILUTION; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; REFERENCE VALUES;

EID: 77649189882     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.06.099     Document Type: Article

References (25)

1. Sirovich B.E., Schwartz L.M., and Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. J Am Med Assoc 289 (2003) 1414-1420
2. Ross L.E., Coates R.J., Breen N., et al. Prostate-specific antigen test use reported in the 2000 national health interview survey. Prev Med 38 (2004) 732-744
3. Baillargeon J., Pollock B.H., Kristal A.R., et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103 (2005) 1092-1095
4. Barqawi A.B., Golden B.K., O'Donnell C., et al. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Urology 65 (2005) 708-712
5. Kristal A.R., Chi C., Tangen C.M., et al. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer 106 (2006) 320-328
6. Fowke J.H., Signorello L.B., Chang S.S., et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 107 (2006) 2361-2367
7. Werny D.M., Thompson T., Saraiya M., et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol Biomarkers Prev 16 (2007) 70-76
8. Bañez L.L., Hamilton R.J., Partin A.W., et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. J Am Med Assoc 298 (2007) 2275-2280
9. Ando R., Nagaya T., Hashimoto Y., et al. Inverse relationship between obesity and serum prostate-specific antigen level in healthy Japanese men: a Hospital-Based Cross-Sectional Survey; 2004-2006. Urology 72 (2008) 561-565
10. Gapstur S.M., Gann P.H., Kopp P., et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11 (2002) 1041-1047
11. Muller M., Den Tonkelaar I., Thijssen J.H., et al. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 149 (2003) 583-589
12. Young C.Y., Montgomery B.T., Andrews P.E., et al. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51 (1991) 3748-3752
13. Sawyer M., and Ratain M.J. Body surface area as a determinant of pharmacokinetics and drug dosing. Invest New Drugs 19 (2001) 171-177
14. Sivanandam A., Siva S., Bhandari M., et al. Variance inflation in sequential calculations of body surface area, plasma volume, and prostate-specific antigen mass. BJU Int 102 (2008) 1573-1580
15. Manzone T.A., Dam H.Q., Soltis D., et al. Blood volume analysis: a new technique and new clinical interest reinvigorate a classic study. J Nucl Med Technol 35 (2007) 55-63
16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
17. Wolff J.M., Ting O., Borchers H., et al. Serum levels of prostate specific antigen in men on hemodialysis. Anticancer Res 20 (2000) 5191-5193
18. Tzanakis I., Kazoulis S., Girousis N., et al. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephron 90 (2002) 230-233
19. Bruun L., Björk T., Lilja H., et al. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment. Nephrol Dial Transplant 18 (2003) 598-603
20. Neuhouser M.L., Rock C.L., Eldridge A.L., et al. Serum concentrations of retinol, alpha-tocopherol and the carotenoids are influenced by diet, race and obesity in a sample of healthy adolescents. J Nutr 131 (2001) 2184-2191
21. Ministry of Health Labour and Welfare. Health State of the Nation, Annual Report. [Japanese] (2008), Health and Welfare Statistics Association, Tokyo
22. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. J Am Med Assoc 270 (1993) 860-864
23. Ochiai A., Fritsche H.A., and Babaian R.J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Urology 66 (2005) 819-823
24. Freedland S.J., Platz E.A., Presti Jr. J.C., et al. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. J Urol 175 (2006) 500-504
25. Fowke J.H., Motley S.S., Cookson M.S., et al. The association between body size, prostate volume and prostate-specific antigen. Prostate Cancer Prostatic Dis 10 (2007) 137-142